Abstract
BackgroundImmune checkpoint inhibitors (ICIs) are a first line and adjuvant treatment in advanced stage lung cancer. One of the main complications of ICI treatment is pneumonitis with an overall incidence...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
